Digomics L.L.C.
-----------------------
AI + omics for Drug R&D
Digomics L.L.C.
-----------------------
AI + omics for Drug R&D

AI+ omics for next generation drug hunter

AI+ omics for next generation drug hunterAI+ omics for next generation drug hunterAI+ omics for next generation drug hunter

AI+ omics for next generation drug hunter

AI+ omics for next generation drug hunterAI+ omics for next generation drug hunterAI+ omics for next generation drug hunter

Technology Platforms

#

NeoTarget™

An AI-enabled target discovery platform

#

NeoBody™

An AI-enabled drug design platform

#

NeoHTS™

A high-throughput wet experiment platform

Subscribe

Sign up to be the first to know about our soft launch events.

Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Better yet, see us in person!

We love our customers, so feel free to visit during normal business hours.

DigOmics LLC

Franklin Street, Brookline, Massachusetts 02445, United States

Hours

Today

Closed

About DigOmics L.L.C.

Our Team

At DigOmics LLC, we have united a team of talented and devoted professionals who share a passion for transforming drug development in the era of AI + omics. Our team comprises biology researchers, software engineers, drug R&D experts, and business professionals, each contributing distinct expertise toward our collective mission.

Our Innovation

At DigOmics LLC, we are driven by a spirit of innovation. By integrating biotechnology and AI, we explore the intricacies of omics to identify precise therapeutic targets, design novel drugs, and validate mechanisms of action for drug development. We continuously challenge existing paradigms to unlock breakthrough solutions that tangibly improve personalized medicine.

Our Impact

At DigOmics, we take pride in the meaningful impact our capabilities have on accelerating drug development for our collaborators worldwide. Our versatile platform has been utilized across therapeutic areas, from cancer to infectious diseases, to aid in the design and validation of novel drug candidates. We remain steadfastly committed to advancing interdisciplinary technologies that push the boundaries of what is possible. Our goal is to continue innovating to improve the success rate of drug development through enhanced prediction, validation, and elucidation of mechanisms of action. 

Copyright © 2024 DigOmics LLC - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept